Ecological impact of the des-F(6)-quinolone, BMS-284756, on the normal intestinal microflora
- 1 April 2002
- journal article
- clinical trial
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 8 (4) , 229-239
- https://doi.org/10.1046/j.1469-0691.2002.00414.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Activities of BMS 284756 (T-3811) against Haemophilus influenzae , Moraxella catarrhalis , and Streptococcus pneumoniae Isolates from SENTRY Antimicrobial Surveillance Program Medical Centers in Latin America (1999)Antimicrobial Agents and Chemotherapy, 2001
- Emergence of Vancomycin-Resistant EnterococciEmerging Infectious Diseases, 2001
- In Vitro and In Vivo Efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumoniaeAntimicrobial Agents and Chemotherapy, 2001
- Antibacterial Spectrum of a Novel Des-Fluoro(6) Quinolone, BMS-284756Antimicrobial Agents and Chemotherapy, 2000
- Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infectionsJournal of Antimicrobial Chemotherapy, 2000
- In Vitro and In Vivo Antimicrobial Activities of T-3811ME, a Novel Des-F(6)-QuinoloneAntimicrobial Agents and Chemotherapy, 1999
- Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997)Diagnostic Microbiology and Infectious Disease, 1998
- Resistance Gene Transfer in Anaerobes: New Insights, New ProblemsClinical Infectious Diseases, 1996
- Effect of the Current Antimicrobial Therapeutic Strategy on Fungal Colonization in Patients with Hematologic MalignanciesCurrent Microbiology, 1996
- Inactivation of Antibiotics and the Dissemination of Resistance GenesScience, 1994